AI-generated summary
The authors report a case study of one 39-year-old woman with central serous chorioretinopathy treated with multiwavelength photobiomodulation. After nine sessions, the abstract reports that fluid resolved and best-corrected visual acuity improved from 55 to 80 letters, with stable vision about one year later. Because this is a single patient without a control group, the authors note that further research is needed to confirm effectiveness.
- Participants
- 1
- Who or what was studied
- One 39-year-old woman with central serous chorioretinopathy
- Limits stated in the abstract
- This is a single-patient case report without a control group, and the authors state that research is needed to confirm effectiveness.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Case report, Retina. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.